By inhibiting EHMT1 and EHMT2, which catalyze H3K9me2, the recovery of synaptic function and transmission lost during the onset of Alzheimer’s was observed, together with an improvement of cognitive deficits in aged FAD mice [103]. The gene discussed is EHMT1; the disease is Cognitive impairment.